» Articles » PMID: 19091545

Data Quality at the Cancer Registry of Norway: an Overview of Comparability, Completeness, Validity and Timeliness

Overview
Journal Eur J Cancer
Specialty Oncology
Date 2008 Dec 19
PMID 19091545
Citations 295
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To provide a comprehensive evaluation of the quality of the data collected on both solid and non-solid tumours at the Cancer Registry of Norway (CRN).

Methods: Established quantitative and semi-quantitative methods were used to assess comparability, completeness, accuracy and timeliness of data for the period 1953-2005, with special attention to the registration period 2001-2005.

Results: The CRN coding and classification system by and large follows international standards, with some further subdivisions of morphology groupings performed in-house. The overall completeness was estimated at 98.8% for the registration period 2001-2005. There remains a variable degree of under-reporting particularly for haematological malignancies (C90-95) and tumours of the central nervous system (C70-72). For the same period, 93.8% of the cases were morphologically verified (site-specific range: 60.0-99.8%). The under-reporting in 2005 due to timely publication is estimated at 2.2% overall, based on the number of cases received at the registry during the following year.

Conclusion: This review suggests the routines in place at the CRN yields comparable data that can be considered reasonably accurate, close-to-complete and timely, thereby justifying our policy of the reporting of annual incidence one year after the year of diagnosis.

Citing Articles

Plasma miR-145-5p Levels and Risk of Future Cancer-Results from the HUNT Study.

Antoun C, Oto J, Morelli V, Hveem K, Braekkan S, Medina P Int J Mol Sci. 2025; 26(5).

PMID: 40076809 PMC: 11899732. DOI: 10.3390/ijms26052191.


Body mass index and risk of connective and soft tissue cancer: results from a large cohort of 1.7 million individuals in Norway.

Aune D, Nordsletten M, Myklebust T, Robsahm T, Skalhegg B, Mala T BMC Cancer. 2025; 25(1):243.

PMID: 39934750 PMC: 11817836. DOI: 10.1186/s12885-025-13637-8.


Cardiorespiratory fitness, cardiac morphology and function, and cardiovascular risk factors in long-term breast cancer survivors compared with non-cancer controls.

Saeter M, Johansen S, Reinertsen K, Thorsen L, Haugaa K, Nilsen T Cardiooncology. 2025; 11(1):1.

PMID: 39755716 PMC: 11699684. DOI: 10.1186/s40959-024-00296-0.


Sex differences in childhood cancer risk following ART conception: a registry-based study.

Oakley L, Kristjansson D, Munthe-Kaas M, Nguyen H, Lee Y, Hanevik H Hum Reprod. 2024; 40(2):382-390.

PMID: 39724532 PMC: 11788205. DOI: 10.1093/humrep/deae285.


Life-style and metabolic factors do not affect risk for glioma: a prospective population-based study (The Cohort of Norway).

Gheorghiu A, Brunborg C, Johannesen T, Helseth E, Zwart J, Wiedmann M Front Oncol. 2024; 14:1471733.

PMID: 39703841 PMC: 11656313. DOI: 10.3389/fonc.2024.1471733.